Edward J. Frech

ORCID: 0000-0001-9135-6341
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Eosinophilic Esophagitis
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Eosinophilic Disorders and Syndromes
  • Hepatitis C virus research
  • Systemic Sclerosis and Related Diseases
  • Dysphagia Assessment and Management
  • Renal Diseases and Glomerulopathies
  • Esophageal and GI Pathology
  • Child Nutrition and Feeding Issues
  • Viral gastroenteritis research and epidemiology
  • Vitamin D Research Studies
  • Respiratory viral infections research
  • Abdominal Surgery and Complications
  • Intestinal and Peritoneal Adhesions
  • Clinical Nutrition and Gastroenterology
  • Tracheal and airway disorders
  • Vasculitis and related conditions
  • Urticaria and Related Conditions
  • Parasitic Infections and Diagnostics
  • Foreign Body Medical Cases
  • Inflammatory mediators and NSAID effects
  • Autoimmune Bullous Skin Diseases
  • Colorectal Cancer Surgical Treatments
  • Cancer, Stress, Anesthesia, and Immune Response

Intermountain Medical Center
2020

University of Utah
2006-2008

Huntsman Cancer Institute
2007

University of Utah Health Care
2007

Lake City VA Medical Center
2007

VA Salt Lake City Healthcare System
2006

Eastern Virginia Medical School
1996-1997

Children's Hospital of The King's Daughters
1996

Pruritus is a common symptom in systemic sclerosis (SSc), an autoimmune disease which causes fibrosis and vasculopathy skin, lung, gastrointestinal tract (GIT). Unfortunately, pruritus has limited treatment options this disease. Pilot trials of low-dose naltrexone hydrochloride (LDN) for pruritus, pain, quality life (QOL) other GIT diseases have been successful. In case series we report three patients that had significant improvement total symptoms as measured by the 10-point faces scale...

10.1155/2011/804296 article EN cc-by International Journal of Rheumatology 2011-01-01

Purpose: Eosinophilic esophagitis (EoE) is an increasingly recognized chronic, inflammatory disorder characterized by dysphagia and eosinophilic infiltration of the esophageal mucosa. While pathogenesis remains poorly understood, recruitment eosinophils believed to occur in response allergens epithelially-derived eotaxin-3. The current diagnosis relies on histologic (>20 eos/hpf) endoscopic (rings furrows) findings. Recent studies have shown that H&E staining significantly underestimates...

10.14309/00000434-200709002-00105 article EN The American Journal of Gastroenterology 2007-09-01

A 37 year-old man was admitted to the trauma service following a rollover ATV accident. Prior accident he in good health. Injuries included L1 burst fracture which required spinal cord decompression. Post-surgical hospital course uneventful. He transferred rehabilitation unit on post-operative day #5 with persistent incomplete paraplegia. On #15 patient developed painful purpuric rash his lower extremities. Punch biopsies were obtained. Several hours later complained of nausea accompanied by...

10.14309/00000434-200609001-00954 article EN The American Journal of Gastroenterology 2006-09-01

A 56 year-old man was admitted with productive cough, fever, and progressive dyspnea. The patient had a long history of tobacco alcohol dependency. He noted to have dysphagia solids, intermittent hoarseness, 30 lb. weight loss over the preceding 6 months. Plain films demonstrated necrotizing right upper lobe pneumonia raising concerns for pulmonary tuberculosis. Chest CT showed circumferential irregular esophageal wall thickening in mid-distal esophagus addition supraclavicular, mediastinal,...

10.14309/00000434-200609001-00957 article EN The American Journal of Gastroenterology 2006-09-01

Introduction: The opioid epidemic generates a high number of hepatitis C virus – nucleic antigen testing (HCV-NAT) positive donors. availability effective direct-acting antiviral (DAA) therapies, presents an opportunity to expand the donor pool. This study describes outcomes at one first centers begin HCV-NAT in NAT negative recipients liver transplantation (LT). Materials and Methods: Prospective, single center study. DAA naïve who received were included. For comparative analysis, cohort...

10.1097/01.tp.0000699852.66805.8e article EN Transplantation 2020-08-28

Introduction: There is scarce literature providing clinical guidance on deep vein thrombosis (DVT) management after liver transplantation (LT), where hemostatic disturbances are constantly changing as the synthetic capacity of increases. We hypothesized that an anticoagulation algorithm based thromboembolism risk would decrease rates and bleeding LT. Materials Methods: Ambispective, single center study. An for DVT LT was developed according to location.Data from patients who received a...

10.1097/01.tp.0000701076.25076.8e article EN Transplantation 2020-08-28
Coming Soon ...